The Company is engaged in restructuring activities, including vendor consolidations and product transfer costs, as part of its sourcing, manufacturing, and supply chain optimization efforts. These activities are expected to result in significant charges and generate savings. The Company prioritizes supply chain continuity and is evolving its generics portfolio toward more profitable products. It serves customers globally through a commercial infrastructure spanning over 165 countries and territories. The Company has a history of FDA approvals for generic versions of various drugs and is developing innovative, patent-protected assets alongside first-to-market generics opportunities.
Viatris Inc's Comment on Supply Chain
The Company is engaged in restructuring activities, including vendor consolidations and product transfer costs, as part of its sourcing, manufacturing, and supply chain optimization efforts. These activities are expected to result in significant charges and generate savings. The Company prioritizes supply chain continuity and is evolving its generics portfolio toward more profitable products. It serves customers globally through a commercial infrastructure spanning over 165 countries and territories. The Company has a history of FDA approvals for generic versions of various drugs and is developing innovative, patent-protected assets alongside first-to-market generics opportunities.
Sources:
Viatris Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Viatris Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
